Advanced Heart Failure and Transplant Cardiology · Nashville, TN
NPI
1942203963
Since 2005
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4230 Harding Pike Ste 900
Nashville, TN, 37205
Phone (615) 964-5841
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,223 services
Medicare patients, 2024
462
Average age 75
Drug cost, 2024
$1.2M
6,359 prescriptions
Company payments, 2025
$475
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacy F Davis was code 93306 (echocardiography (tte/tee)), 266 times for 262 patients. In total Stacy F Davis billed 1,223 services in 28 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 266 | 262 | $44.43 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 165 | 61 | $83.93 | $14K |
| 99214 Office E&M - Established | Office | 148 | 131 | $82.71 | $12K |
| 99215 Office E&M - Established | Office | 142 | 113 | $123.46 | $18K |
| 99291 Critical Care E&M | Facility | 68 | 22 | $140.95 | $9,585 |
| 99223 Hospital E&M - Initial | Facility | 56 | 49 | $120.50 | $6,748 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 44 | $12.17 | $535 |
| 93018 Electrocardiogram | Facility | 41 | 41 | $9.29 | $381 |
| 78452 Myocardial Perfusion Scan | Facility | 39 | 39 | $48.30 | $1,884 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 17 | $52.77 | $1,741 |
| 93356 Echocardiography (TTE/TEE) | Facility | 28 | 28 | $7.81 | $219 |
| 93016 Electrocardiogram | Facility | 21 | 21 | $13.90 | $292 |
| 76376 CT Scan | Facility | 16 | 16 | $6.55 | $105 |
| 93248 Electrocardiogram | Facility | 15 | 11 | $18.79 | $282 |
| 99205 Office E&M - New | Office | 14 | 14 | $159.68 | $2,235 |
By year: 2022 $147K for 2,056 services; 2023 $122K for 1,634 services; 2024 $81K for 1,223 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 33 | 33 | $10.48 | $346 |
| 80061 Clinical Chemistry | 24 | 24 | $13.29 | $319 |
Medicare prescription drug claims, 2024
In 2024, the drug Stacy F Davis prescribed most often to Medicare patients was Metoprolol Succinate, with 707 prescriptions and refills. In total Stacy F Davis wrote 6,359 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 707 | 1,898 | 213 | $12K |
| Furosemide Generic | 521 | 1,354 | 165 | $3,339 |
| Atorvastatin Calcium Generic | 492 | 1,369 | 156 | $5,712 |
| Entresto Sacubitril/Valsartan | 395 | 691 | 98 | $445K |
| Spironolactone Generic | 324 | 811 | 99 | $2,699 |
| Potassium Chloride Generic | 261 | 671 | 93 | $6,196 |
| Eliquis Apixaban | 221 | 410 | 57 | $238K |
| Carvedilol Generic | 197 | 490 | 56 | $2,301 |
| Torsemide Generic | 190 | 494 | 59 | $4,661 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 182 | 501 | 57 | $3,051 |
| Amlodipine Besylate Generic | 181 | 509 | 57 | $1,066 |
| Lisinopril Generic | 172 | 477 | 50 | $1,629 |
| Jardiance Empagliflozin | 169 | 314 | 39 | $177K |
| Hydralazine Hcl Generic | 159 | 380 | 44 | $3,129 |
| Losartan Potassium Generic | 158 | 447 | 56 | $1,756 |
Brand drugs: 1,183 claims; generic drugs: 5,176 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacy F Davis $475 ($475 in general payments such as food, travel and fees) from 10 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $114.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 5 | $114 |
| Lilly USA, LLC LLY | 5 | $80.8 |
| Pfizer Inc. PFE | 3 | $60.8 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $50.76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.86 |
| Amgen Inc. AMGN | 2 | $30.56 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $29.54 |
| Exact Sciences Corporation EXAS | 2 | $29.06 |
| Inspire Medical Systems, Inc. INSP | 1 | $27.42 |
| Merck Sharp & Dohme LLC MRK | 1 | $16.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.